{"id":"https://openalex.org/W2646510","doi":"https://doi.org/10.1182/blood.v122.21.685.685","title":"A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma","display_name":"A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma","alternate_titles":[],"publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W2646510","doi":"https://doi.org/10.1182/blood.v122.21.685.685","mag":"2646510"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.685.685","doi":"https://doi.org/10.1182/blood.v122.21.685.685","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.685.685","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2646510"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067110512","display_name":"Sara Bringhen","orcid":"https://orcid.org/0000-0003-4539-6363","observed_orcids":["https://orcid.org/0000-0003-4539-6363"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Sara Bringhen","raw_affiliation_strings":["Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068788936","display_name":"Chiara Cerrato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Chiara Cerrato","raw_affiliation_strings":["Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045814742","display_name":"Maria Teresa Petrucci","orcid":"https://orcid.org/0000-0003-0688-4882","observed_orcids":["https://orcid.org/0000-0003-0688-4882"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Maria Teresa Petrucci","raw_affiliation_strings":["Division of Hematology, Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy,","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103564457","display_name":"Mariella Genuardi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Mariella Genuardi","raw_affiliation_strings":["Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029843271","display_name":"Fabiana Gentilini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112021","display_name":"Fondazione Gimema Onlus","ror":"https://ror.org/01b3n9g22","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210112021"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Fabiana Gentilini","raw_affiliation_strings":["Italian Multiple Myeloma Network, GIMEMA, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Italian Multiple Myeloma Network, GIMEMA, Italy,","institution_ids":["https://openalex.org/I4210112021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003679742","display_name":"Concetta Conticello","orcid":"https://orcid.org/0000-0003-0862-3598","observed_orcids":["https://orcid.org/0000-0003-0862-3598"]},"institutions":[{"id":"https://openalex.org/I4210112021","display_name":"Fondazione Gimema Onlus","ror":"https://ror.org/01b3n9g22","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210112021"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Concetta Conticello","raw_affiliation_strings":["Italian Multiple Myeloma Network, GIMEMA, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Italian Multiple Myeloma Network, GIMEMA, Italy,","institution_ids":["https://openalex.org/I4210112021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102895357","display_name":"Stefania Oliva","orcid":"https://orcid.org/0009-0009-7274-3552","observed_orcids":["https://orcid.org/0009-0009-7274-3552"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Stefania Oliva","raw_affiliation_strings":["Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040474758","display_name":"Lucia Pantani","orcid":"https://orcid.org/0000-0002-0768-0235","observed_orcids":["https://orcid.org/0000-0002-0768-0235"]},"institutions":[{"id":"https://openalex.org/I4210112021","display_name":"Fondazione Gimema Onlus","ror":"https://ror.org/01b3n9g22","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210112021"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Lucia Pantani","raw_affiliation_strings":["Italian Multiple Myeloma Network, GIMEMA, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Italian Multiple Myeloma Network, GIMEMA, Italy,","institution_ids":["https://openalex.org/I4210112021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083644983","display_name":"Massimo Offidani","orcid":"https://orcid.org/0000-0003-2749-7347","observed_orcids":["https://orcid.org/0000-0003-2749-7347"]},"institutions":[{"id":"https://openalex.org/I4210112021","display_name":"Fondazione Gimema Onlus","ror":"https://ror.org/01b3n9g22","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210112021"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Massimo Offidani","raw_affiliation_strings":["Italian Multiple Myeloma Network, GIMEMA, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Italian Multiple Myeloma Network, GIMEMA, Italy,","institution_ids":["https://openalex.org/I4210112021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112542062","display_name":"Carmela Palladino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Carmela Palladino","raw_affiliation_strings":["Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026430732","display_name":"Giulia Benevolo","orcid":"https://orcid.org/0000-0002-3200-9654","observed_orcids":["https://orcid.org/0000-0002-3200-9654"]},"institutions":[{"id":"https://openalex.org/I4210112021","display_name":"Fondazione Gimema Onlus","ror":"https://ror.org/01b3n9g22","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210112021"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giulia Benevolo","raw_affiliation_strings":["Italian Multiple Myeloma Network, GIMEMA, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Italian Multiple Myeloma Network, GIMEMA, Italy,","institution_ids":["https://openalex.org/I4210112021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068769311","display_name":"Vittorio Montefusco","orcid":"https://orcid.org/0000-0001-7842-3386","observed_orcids":["https://orcid.org/0000-0001-7842-3386"]},"institutions":[{"id":"https://openalex.org/I4210112021","display_name":"Fondazione Gimema Onlus","ror":"https://ror.org/01b3n9g22","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210112021"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Vittorio Montefusco","raw_affiliation_strings":["Italian Multiple Myeloma Network, GIMEMA, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Italian Multiple Myeloma Network, GIMEMA, Italy,","institution_ids":["https://openalex.org/I4210112021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112261034","display_name":"Monica Astolfi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Monica Astolfi","raw_affiliation_strings":["Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063836948","display_name":"Oreste Villani","orcid":"https://orcid.org/0000-0003-2413-6239","observed_orcids":["https://orcid.org/0000-0003-2413-6239"]},"institutions":[{"id":"https://openalex.org/I4210112021","display_name":"Fondazione Gimema Onlus","ror":"https://ror.org/01b3n9g22","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210112021"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Oreste Villani","raw_affiliation_strings":["Italian Multiple Myeloma Network, GIMEMA, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Italian Multiple Myeloma Network, GIMEMA, Italy,","institution_ids":["https://openalex.org/I4210112021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103869918","display_name":"Agostina Siniscalchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112021","display_name":"Fondazione Gimema Onlus","ror":"https://ror.org/01b3n9g22","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210112021"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Agostina Siniscalchi","raw_affiliation_strings":["Italian Multiple Myeloma Network, GIMEMA, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Italian Multiple Myeloma Network, GIMEMA, Italy,","institution_ids":["https://openalex.org/I4210112021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033110908","display_name":"Alberto Rocci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alberto Rocci","raw_affiliation_strings":["Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy,","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017532694","display_name":"Lorenzo De Paoli","orcid":"https://orcid.org/0000-0002-7488-8247","observed_orcids":["https://orcid.org/0000-0002-7488-8247"]},"institutions":[{"id":"https://openalex.org/I4210112021","display_name":"Fondazione Gimema Onlus","ror":"https://ror.org/01b3n9g22","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210112021"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Lorenzo De Paoli","raw_affiliation_strings":["Italian Multiple Myeloma Network, GIMEMA, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Italian Multiple Myeloma Network, GIMEMA, Italy,","institution_ids":["https://openalex.org/I4210112021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018139001","display_name":"Mario Boccadoro","orcid":"https://orcid.org/0000-0001-8130-5209","observed_orcids":["https://orcid.org/0000-0001-8130-5209"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Mario Boccadoro","raw_affiliation_strings":["Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002972322","display_name":"Pieter Sonneveld","orcid":"https://orcid.org/0000-0002-0808-2237","observed_orcids":["https://orcid.org/0000-0002-0808-2237"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Pieter Sonneveld","raw_affiliation_strings":["Erasmus University Medical Center, Rotterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erasmus University Medical Center, Rotterdam, Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059967673","display_name":"Antonio Pierangelo Palumbo","orcid":"https://orcid.org/0000-0002-1763-6609","observed_orcids":["https://orcid.org/0000-0002-1763-6609"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonio Palumbo","raw_affiliation_strings":["Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy,","institution_ids":["https://openalex.org/I55143463"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5003679742","https://openalex.org/A5017532694","https://openalex.org/A5018139001","https://openalex.org/A5026430732","https://openalex.org/A5029843271","https://openalex.org/A5033110908","https://openalex.org/A5040474758","https://openalex.org/A5045814742","https://openalex.org/A5063836948","https://openalex.org/A5067110512","https://openalex.org/A5068769311","https://openalex.org/A5068788936","https://openalex.org/A5083644983","https://openalex.org/A5102895357","https://openalex.org/A5103564457","https://openalex.org/A5103869918","https://openalex.org/A5112261034","https://openalex.org/A5112542062"],"corresponding_institution_ids":["https://openalex.org/I4210112021","https://openalex.org/I55143463","https://openalex.org/I861853513"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"122","issue":"21","first_page":"685","last_page":"685"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":0.9279999732971191},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8700000047683716},{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.9639999866485596},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7950000166893005},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.8090000152587891},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.984000027179718},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7089999914169312},{"id":"https://openalex.org/keywords/near-complete-response","display_name":"near complete response","score":0.5569999814033508},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6809999942779541},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9200000166893005},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9010000228881836},{"id":"https://openalex.org/keywords/frailty","display_name":"frailty","score":0.5730000138282776},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.382999986410141},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.5189999938011169},{"id":"https://openalex.org/keywords/transplant-ineligible-patients","display_name":"transplant-ineligible patients","score":0.5590000152587891},{"id":"https://openalex.org/keywords/geriatric-assessment","display_name":"geriatric assessment","score":0.48100000619888306},{"id":"https://openalex.org/keywords/frailty-index","display_name":"frailty index","score":0.3720000088214874},{"id":"https://openalex.org/keywords/charlson-comorbidity-index","display_name":"Charlson Comorbidity Index","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.9595457315444946},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9073069095611572},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.7004727721214294},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6976189613342285},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5824260711669922},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5395371913909912},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5368718504905701},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.477779746055603},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4255579113960266},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.399925172328949},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.32457005977630615},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.255638986825943},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.2265651524066925}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.685.685","doi":"https://doi.org/10.1182/blood.v122.21.685.685","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.685.685","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2568062489","https://openalex.org/W2513834994","https://openalex.org/W2088674645","https://openalex.org/W2596209258","https://openalex.org/W4229965854","https://openalex.org/W2550148010","https://openalex.org/W2580728155","https://openalex.org/W2528151402","https://openalex.org/W2905846282","https://openalex.org/W2771818728"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"The":[2,63,243,359,421],"current":[3],"treatment":[4],"for":[5,15,135,338],"newly":[6,58],"diagnosed":[7,59],"elderly":[8,57],"multiple":[9],"myeloma":[10],"(MM)":[11],"patients,":[12],"not":[13,388],"eligible":[14],"transplant,":[16],"induces":[17],"approximately":[18,445],"30%":[19],"near-complete":[20],"response/complete":[21],"response":[22],"(nCR/CR).":[23],"Carfilzomib":[24,385],"is":[25,161,424,465],"a":[26,342,459],"novel,":[27],"irreversible":[28],"proteasome-inhibitor":[29],"with":[30,141,215,390,453,468],"significant":[31],"activity":[32],"and":[33,44,49,65,75,96,109,194,210,213,248,284,298,321,387,404,429,440],"favourable":[34],"toxicity":[35,362],"profile,":[36],"including":[37,240,355],"very":[38],"low":[39],"rates":[40],"of":[41,51,171,230,296,316,324,345,347,475],"peripheral":[42],"neuropathy":[43,291,411],"neutropenia.":[45],"We":[46],"evaluated":[47],"efficacy":[48,74],"safety":[50],"the":[52,249,309,350,381,384,454,489],"combination":[53],"carfilzomib-cyclophosphamide-dexamethasone":[54],"(CCd)":[55],"in":[56,301,370,375,461],"MM":[60],"patients.":[61],"Methods":[62],"Bryant":[64],"Day":[66],"two-stage":[67],"design":[68],"was":[69,167,246,252,292,299,312,353,367,398],"used":[70],"to":[71,200,303,332,481],"evaluate":[72],"both":[73],"safety.":[76],"Patients":[77],"received":[78],"oral":[79,86],"cyclophosphamide":[80],"(300":[81],"mg/m2":[82,104,111,121,145],"on":[83,90,105,112,122,146],"days":[84,91,106,113,123,134,147,154],"1,8,15),":[85],"dexamethasone":[87],"(40":[88],"mg":[89],"1,":[92,107,124,148],"8,":[93,114,126],"15,":[94,116,128,150],"22)":[95],"iv":[97,142],"carfilzomib":[98,143],"administered":[99],"over":[100],"30":[101],"minutes":[102],"(20":[103],"2,":[108,125,149],"36":[110,120],"9,":[115,127],"16,":[117,129],"cycle":[118],"1;":[119],"cycles":[130],"2-9)":[131],"every":[132,152],"28":[133,153],"9":[136,226,434],"cycles,":[137,228,435],"followed":[138],"by":[139,294],"maintenance":[140,339,346,366],"(36":[144],"16)":[151],"until":[155],"progression":[156],"or":[157,189,192,306],"intolerance.":[158],"Results":[159],"Enrollment":[160],"complete":[162],"(58":[163],"pts):":[164],"median":[165,343],"age":[166,214],"71":[168],"years,":[169,177],"28%":[170],"patients":[172,222,231,297,317,325,335,476],"were":[173,267,336],"older":[174],"than":[175],"75":[176],"40%":[178],"had":[179,184],"ISS":[180],"stage":[181],"III,":[182],"35%":[183],"unfavorable":[185],"FISH":[186],"profile":[187],"[t(4;14)":[188],"t":[190],"(14;16)":[191],"del17p]":[193],"31%":[195],"are":[196],"frail,":[197],"defined":[198],"according":[199],"Charlson":[201],"co-morbidity":[202],"index":[203],"(\u22652),":[204],"geriatric":[205],"assessment":[206],"score":[207],"ADL":[208],"(<4)":[209],"IADL":[211],"(<5)":[212],"cut-off":[216],"setting":[217],"at":[218,233,488],"80":[219],"years.":[220],"Twenty-five":[221,334],"completed":[223],"induction.":[224],"After":[225,341],"induction":[227,330],"96%":[229],"achieved":[232],"least":[234,438],"PR,":[235],"76%":[236],"VGPR,":[237],"64%":[238,436],"CR/nCR,":[239],"24%":[241,441],"stringent-CR.":[242],"1-year":[244,250],"PFS":[245],"86%":[247],"OS":[251],"87%.":[253],"Grade":[254],"(G)":[255],"4":[256],"hematologic":[257],"AE":[258],"included":[259],"neutropenia":[260,403],"(3":[261,273],"pts,":[262,270,274,278,282],"5%).":[263],"G3-4":[264],"non-hematologic":[265],"AEs":[266],"infections":[268],"(4":[269],"7%),":[271],"cardiac":[272],"5%),":[275],"constitutional":[276],"(2":[277,281,414],"4%),":[279],"renal":[280],"4%)":[283],"gastrointestinal":[285],"complications":[286],"(1":[287],"pt,":[288],"2%).":[289],"Peripheral":[290,410],"experienced":[293],"11%":[295,323,474],"limited":[300,413,469],"severity":[302],"grade":[304,470],"1":[305,400,405],"2.":[307],"Overall,":[308],"CCd":[310,422],"regimen":[311,423],"well":[313,466],"tolerated,":[314],"20%":[315],"required":[318,326,477],"dose":[319],"reduction":[320],"only":[322,399,473],"drug":[327,478],"discontinuation":[328,479],"during":[329,365,380,447],"due":[331,480],"AEs.":[333,482],"assessable":[337],"treatment.":[340],"duration":[344],"6":[348,371],"months,":[349],"PR":[351],"rate":[352],"100%,":[354],"68%":[356],"CR/nCR":[357],"(Table).":[358],"most":[360],"frequent":[361],"(all":[363],"grades)":[364],"fever":[368],"(G1-2":[369],"pts":[372,377,415],"[24%],":[373],"G3":[374,402],"2":[376],"[8%]),":[378],"occurring":[379],"evening":[382],"following":[383],"infusion":[386],"associated":[389],"chills,":[391],"rigors,":[392],"dyspnea":[393],"and/or":[394],"creatinine":[395],"increase.":[396],"There":[397],"(4%)":[401,406],"G2":[407],"pericardial":[408],"effusion.":[409],"remained":[412],"[8%],":[416],"all":[417],"G":[418],"1-2).":[419],"Conclusions":[420],"highly":[425],"active,":[426],"showing":[427,458],"rapid":[428],"deep":[430],"responses,":[431],"reaching":[432],"after":[433],"(at":[437],"nCR)":[439],"sCR,":[442],"further":[443],"improving":[444],"10-15%":[446],"maintenance.":[448],"These":[449],"responses":[450],"compare":[451],"favorably":[452],"best":[455],"frontline":[456],"regimens,":[457],"doubling":[460],"nCR":[462],"rate.":[463],"It":[464],"tolerated":[467],"3-4":[471],"AEs,":[472],"An":[483],"update":[484],"will":[485],"be":[486],"presented":[487],"meeting.":[490],"Disclosures:":[491],"Bringhen:":[492],"Onyx:":[493,516],"Consultancy.":[494],"Sonneveld:Onyx:":[495],"Honoraria,":[496],"Research":[497],"Funding.":[498],"Palumbo:Amgen:":[499],"Consultancy,":[500,504,507,511,514,517],"Honoraria;":[501,505,508,512,515],"Bristol-Myers":[502],"Squibb:":[503],"Celgene:":[506],"Janssen":[509],"Pharmaceuticals:":[510],"Millenium:":[513],"Honoraria.":[518]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2646510","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
